On the road to biological blood diagnosis of Alzheimer's disease? Vers un diagnostic biologique sanguin de la maladie d Alzheimer ?
Delaby, Constance (Institut de Recerca Sant Pau)
Lehmann, Sylvain (Université Montpellier)
Universitat Autònoma de Barcelona

Date:	2024
Abstract:	The growing number of people suffering from Alzheimer s disease (AD) represents a major public health problem. The diagnosis of AD is multidisciplinary and involves the use of amyloid and tau biomarkers measured in cerebrospinal fluid. Recent advances in analytical techniques now allow us to measure these biomarkers in blood. Blood biomarkers offer particularly promising potential for early, minimally invasive detection of AD, as well as for differential diagnosis of dementia and patient follow-up. The aim of this review is to provide an overview of current and candidate blood biomarkers for AD, their informative value, and their potential to be integrated into clinical practice in the near future.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Francès
Document:	Article ; recerca ; Versió publicada
Subject:	Alzheimer Disease ; Amyloid beta-Peptides ; Biomarkers ; Diagnosis, Differential ; Humans ; Tau Proteins
Published in:	Medecine/Sciences, Vol. 40 Núm. 4 (janvier 2024) , p. 351-360, ISSN 1958-5381

DOI: 10.1051/medsci/2024037
PMID: 38651960

9 p, 2.0 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles